Clinical trial
Intermittent Preventive Treatment of Malaria With Sulfadoxine-Pyrimethamine in Different Zones of Drug Resistance in Rwanda
NCT00372632 is registered in ClinicalTrials.gov with Institute of Tropical Medicine, Belgium as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intermittent Preventive Treatment of Malaria With Sulfadoxine-Pyrimethamine in Different Zones of Drug Resistance in Rwanda
- Lead sponsor
- Institute of Tropical Medicine, Belgium
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2005
- Completion date
- April 30, 2008
- Enrollment
- 1,717 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non hiv infected pregnant women